This study investigates warm autoimmune hemolytic anemia (wAIHA). Participants will be in the study for up to 24 weeks in the primary analysis period, followed by 28 weeks in an open-label period, and potentially up to 52 weeks in a long-term extension, depending on response. The purpose is to evaluate …
This study investigates the effects of an investigational medication on adults with moderate to severe Crohn's Disease. The purpose is to evaluate the safety and effectiveness of different doses compared to a placebo. Participants will be in the study for up to 59 weeks, including a 4-week screening period, 52 …
This study investigates the effectiveness and safety of an investigational medication compared to the usual treatment of intravenous immunoglobulin (IVIg) in adults with chronic inflammatory demyelinating polyneuropathy (CIDP). Participants will be in the study for up to 25 months, which is about 2 years.During the study, participants will receive either …
This study investigates chronic inflammatory demyelinating polyneuropathy (CIDP). The study aims to evaluate the effectiveness and safety of an investigational medication compared to a placebo in adults with CIDP who do not respond to usual treatments. Participants will be involved in the study for up to 25 months, which is …
This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis. Participants will be in the study for up to 59 weeks, including a 28-day screening period, a 52-week main treatment period, and a 2-week follow-up. The main treatment period consists of a 12-week …
This study investigates the effects of an investigational medication on Type 1 diabetes. The purpose of the study is to compare the investigational medication with a placebo in adults and adolescents who are also receiving insulin therapy. Participants will be involved in the study for up to 135 weeks.Study procedures …
This study investigates the effects of an investigational medication compared to a placebo in young people with Stage 3 Type 1 diabetes. The study aims to observe changes in blood sugar control and the need for insulin over 52 weeks. Participants will be involved in the study for about 84 …
This study investigates the effectiveness and safety of an investigational medication compared to a placebo for treating chronic lung allograft dysfunction (CLAD) in adults. Participants will have already undergone a bilateral lung transplant and will be receiving a standard treatment regimen including azithromycin and immunosuppression therapies.Participants in the study will …
This study investigates the effects of an investigational medication on adults with moderate to severe Ulcerative Colitis. The study aims to compare different doses of the investigational medication to a placebo to understand its efficacy and safety.Participants in the study will be randomly assigned to one of three study arms. …
This study investigates chronic rhinosinusitis with nasal polyps. The purpose of this study is to evaluate the effects of an investigational medication compared to a placebo, alongside usual nasal sprays, in adults with this condition.Participants will receive either the investigational medication or a placebo, which is an inactive substance that …
